From surging raw material prices to looming tariffs on imported APIs, pharmaceutical buyers in 2025 are undergoing inflationary pressure from every corner.
2020, the year of the COVID-19 pandemic, presented significant challenges to every market in the world. However, the pharmaceutical market has still been able to adapt to this new situation and continues to grow quickly.